Colorectal Cancer: Screening Tests, Symptoms, and Treatment Pathways

Colorectal cancer is a cancer that begins in the colon or rectum and is often treatable, especially when found early through screening. Understanding warning symptoms, screening options, and treatment pathways can help patients make informed decisions with their healthcare team.

Overview

Colorectal cancer is a malignant disease that starts in the large intestine, which includes the colon and the rectum. Cancer in the colon is often called colon cancer, while cancer in the rectum is called rectal cancer. Because these conditions share many risk factors, screening methods, and treatments, they are commonly discussed together as colorectal cancer.

Many colorectal cancers begin as small growths called polyps on the inner lining of the bowel. Not all polyps become cancer, but some types can slowly develop abnormal changes over several years. This long development period is one reason screening is so valuable: it can identify cancer at an early stage and may also prevent cancer by finding and removing precancerous polyps.

Colorectal cancer care is highly individualized. The most appropriate pathway depends on where the tumor is located, whether it has spread, the results of biopsy and molecular tests, and the person’s general health and preferences. With modern diagnostic tools and multidisciplinary care, many patients can receive a clear plan that balances cancer control, bowel function, and quality of life.

Symptoms of Colorectal Cancer

Early colorectal cancer may not cause noticeable symptoms. This is why screening is recommended for people at average risk starting at an age advised by national guidelines, and earlier for those with higher risk. When symptoms do occur, they may be mild at first or resemble common digestive problems, so persistent changes should be assessed by a doctor.

Possible symptoms include a change in bowel habits, such as diarrhea, constipation, narrower stools, or a feeling that the bowel does not empty completely. Some people notice blood in or on the stool, dark stools, rectal bleeding, abdominal pain, bloating, cramping, or unexplained fatigue. Iron-deficiency anemia may also be discovered on a blood test, particularly when slow bleeding is present.

Symptoms can vary depending on the location of the tumor. Right-sided colon cancers may be more likely to cause anemia and tiredness, while left-sided colon or rectal tumors may more often cause visible bleeding or changes in stool shape and frequency. These patterns are not absolute, and a medical evaluation is needed to determine the cause.

Causes and Risk Factors

Colorectal cancer develops when cells in the lining of the colon or rectum acquire genetic changes that allow them to grow in an uncontrolled way. In most people, these changes occur over time and are not inherited. In a smaller proportion of patients, an inherited syndrome increases lifetime risk and may require earlier or more intensive screening.

Risk factors for colorectal cancer include increasing age, a personal history of colorectal polyps or colorectal cancer, inflammatory bowel disease such as ulcerative colitis or Crohn’s colitis, and a family history of colorectal cancer or advanced polyps. Hereditary conditions such as Lynch syndrome and familial adenomatous polyposis are important to recognize because they can affect both the patient and relatives.

Lifestyle-related factors can also influence risk. These include smoking, heavy alcohol use, low physical activity, obesity, and dietary patterns high in processed meats and low in fiber-rich foods. Having one or more risk factors does not mean a person will develop colorectal cancer, but it may help guide screening and prevention planning.

• Average risk: no personal history, strong family history, or known inherited syndrome.
• Increased risk: prior polyps, family history, inflammatory bowel disease, or certain genetic conditions.
• Modifiable factors: physical activity, weight management, tobacco avoidance, alcohol moderation, and diet quality.

Screening Tests and Diagnosis

Screening looks for colorectal cancer or precancerous polyps before symptoms appear. The best screening test is the one that is appropriate for the individual and completed at the recommended interval. A doctor can advise when to start, how often to repeat screening, and whether family history or other risk factors require a different schedule.

Common screening options include stool-based tests and visual examinations of the colon and rectum. Stool tests can detect hidden blood or certain DNA changes linked to cancer and advanced polyps. Colonoscopy allows the doctor to view the entire colon, take biopsies, and remove many polyps during the same procedure. Other tests, such as flexible sigmoidoscopy or CT colonography, may be used in selected situations.

If colorectal cancer is suspected, diagnosis is confirmed with a biopsy, usually taken during colonoscopy or sigmoidoscopy. The tissue sample is examined by a pathologist to identify cancer type and features. Additional tests may include blood tests, imaging such as CT or MRI, and sometimes PET/CT, depending on the case. Rectal cancer often requires pelvic MRI or endorectal ultrasound to evaluate local extent and plan treatment.

Molecular testing of the tumor is increasingly important. Tests may look for mismatch repair deficiency or microsatellite instability, as well as mutations in genes such as RAS, BRAF, or others when advanced disease is present. These results can help guide targeted therapy, immunotherapy, and family risk assessment.

Staging and Treatment Planning

Staging describes how far colorectal cancer has spread. In general, early-stage cancer is limited to the bowel wall, regional-stage cancer involves nearby lymph nodes or tissues, and metastatic cancer has spread to distant organs such as the liver or lungs. Staging helps the care team estimate prognosis and select the most appropriate treatment sequence.

Treatment planning is usually multidisciplinary. A team may include a gastroenterologist, colorectal surgeon, medical oncologist, radiation oncologist, radiologist, pathologist, oncology nurse, dietitian, and stoma care specialist when needed. This team approach is especially important for rectal cancer, complex surgery, or disease that has spread to the liver, lungs, or peritoneum.

Patient factors are also central to decision-making. Age alone does not determine treatment; overall health, other medical conditions, nutritional status, personal goals, and expected side effects all matter. Patients are encouraged to ask what the stage means, whether the cancer is curable or controllable, what treatment options exist, and how each option may affect daily life.

Treatment Options

Surgery is a main treatment for many colorectal cancers. For colon cancer, surgery usually removes the section of colon containing the tumor along with nearby lymph nodes. For rectal cancer, the operation may be more technically complex because of the pelvis and the need to preserve bowel, urinary, and sexual function when possible. Some patients may need a temporary or permanent stoma, depending on tumor location and the type of surgery.

Chemotherapy may be used after surgery to reduce the risk of recurrence, especially when lymph nodes are involved or other high-risk features are present. In some cases, chemotherapy is given before surgery to shrink the tumor or treat microscopic disease. The exact regimen and duration depend on the cancer stage, tumor biology, and the patient’s ability to tolerate treatment.

Radiotherapy is most often used for rectal cancer rather than colon cancer. It may be given before surgery, sometimes together with chemotherapy, to reduce tumor size and improve the chance of complete removal. In selected patients with rectal cancer who respond very well to non-surgical treatment, careful observation may be discussed in expert centers, but this approach requires strict follow-up and is not suitable for everyone.

For advanced or metastatic colorectal cancer, treatment may include chemotherapy, targeted therapies, immunotherapy, local treatments for liver or lung metastases, or palliative procedures to relieve symptoms. Immunotherapy can be particularly useful for tumors with mismatch repair deficiency or high microsatellite instability. The goal may be cure in selected cases, long-term control, symptom relief, or maintaining quality of life, depending on the situation.

Prevention, Self-Care, and Follow-Up

Not all colorectal cancers can be prevented, but risk can often be reduced. Regular screening is the most important preventive step for eligible adults because it can find precancerous polyps before they become cancer. People with a family history or inherited risk should discuss individualized screening with a specialist.

Healthy daily habits may support lower risk and better overall health. A balanced diet rich in vegetables, fruits, legumes, and whole grains, along with regular physical activity and maintaining a healthy weight, is generally recommended. Avoiding tobacco and limiting alcohol can also reduce cancer and cardiovascular risks.

After colorectal cancer treatment, follow-up care helps monitor recovery and check for recurrence. This may include physical examinations, blood tests such as carcinoembryonic antigen when appropriate, colonoscopy, and imaging at intervals recommended by the treating team. Follow-up is also an opportunity to address bowel changes, neuropathy, fatigue, sexual health, emotional wellbeing, nutrition, and return to work or travel.

Patients receiving care away from home should keep copies of pathology reports, operation notes, imaging results, treatment summaries, and medication lists. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat colorectal cancer for international patients, including coordination of imaging, surgery, oncology care, and follow-up planning when appropriate.

When to See a Doctor

A doctor should be consulted if bowel changes persist, especially when they last more than a few weeks or are accompanied by bleeding, unexplained weight loss, abdominal pain, or fatigue. Rectal bleeding should not be assumed to be caused by hemorrhoids without medical assessment, particularly in adults who are due for screening or have risk factors.

People should also seek medical advice if they have iron-deficiency anemia, a strong family history of colorectal cancer, a known inherited cancer syndrome, or inflammatory bowel disease involving the colon. These situations may require earlier evaluation and a tailored screening plan.

Anyone diagnosed with colorectal cancer may benefit from discussing the case in a multidisciplinary setting and asking whether additional tests, such as MRI for rectal cancer or molecular tumor testing, are needed. Seeking clarification or a second opinion can help patients feel more confident about the treatment pathway.

Frequently asked questions

At what age should colorectal cancer screening start?

Screening age depends on national guidelines and individual risk. Many guidelines recommend starting at midlife for average-risk adults, while people with a family history, inherited syndrome, inflammatory bowel disease, or prior polyps may need earlier screening. A doctor can recommend the most suitable starting age and test interval.

Is colonoscopy the only screening test for colorectal cancer?

No. Stool-based tests, flexible sigmoidoscopy, CT colonography, and colonoscopy are among the available options. Colonoscopy is unique because it allows the doctor to inspect the bowel, take biopsies, and remove many polyps during the same procedure. If a stool test is abnormal, colonoscopy is usually needed to find the cause.

Does blood in the stool always mean colorectal cancer?

Blood in the stool can have many causes, including hemorrhoids, anal fissures, inflammation, polyps, or cancer. However, it should be evaluated rather than ignored, especially if it is persistent or occurs with changes in bowel habits, anemia, or weight loss. A healthcare professional can decide which tests are needed.

Can colorectal cancer be cured?

Many colorectal cancers can be treated successfully, particularly when diagnosed at an early stage and removed completely. Outcomes depend on the stage, tumor biology, general health, and response to treatment. Even when cancer has spread, modern treatment can often control disease and relieve symptoms.

What is the difference between colon cancer and rectal cancer treatment?

Colon cancer is often treated first with surgery, followed by chemotherapy when indicated. Rectal cancer may require radiotherapy, chemotherapy, or both before surgery because of the rectum’s location in the pelvis and the importance of local control. The treatment plan is individualized after imaging, biopsy, and staging.

Will treatment always require a stoma?

No. Many patients do not need a stoma, and some stomas are temporary while the bowel heals after surgery. Whether a stoma is needed depends on tumor location, the type of operation, emergency circumstances, and healing risk. If a stoma is planned, specialized stoma nurses can provide education and support.

References

• World Health Organization
• National Cancer Institute
• American Cancer Society
• European Society for Medical Oncology
• National Comprehensive Cancer Network

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.